You have 9 free searches left this month | for more free features.

Doxorrubicin

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Soft-tissue Sarcoma Trial (LB-100 plus Doxorrubicin, Doxorubicin)

Not yet recruiting
  • Advanced Soft-tissue Sarcoma
  • (no location specified)
Apr 11, 2023

Breast Cancer Trial in Brazil (Docetaxel or Paclitaxel, Cyclophosphamide + Doxorrubicin)

Recruiting
  • Breast Cancer
  • Docetaxel or Paclitaxel
  • Cyclophosphamide + Doxorrubicin
  • Goiânia, Goiás, Brazil
  • +9 more
Jan 5, 2023

BRCA1 Hereditary Breast and Ovarian Cancer Syndrome Trial in Barretos (Doxorubicin, Carboplatin, Paclitaxel)

Completed
  • BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
  • Barretos, SP, Brazil
    Barretos Cancer Hospital
Dec 25, 2022

Breast Tumors Trial (Mitoquinone, Placebo)

Not yet recruiting
  • Breast Neoplasms
  • (no location specified)
Mar 31, 2022

Sarcoma Trial in Spain (Doxorubicin, Trabectedin)

Terminated
  • Sarcoma
  • L'Hospitalet, Barcelona, Spain
  • +19 more
Oct 26, 2015

Locally Advanced HER2-positive Breast Cancer Trial in Sao Paulo (Drug: Paclitaxel; trastuzumab; doxorrubicin; cyclophosphamide)

Terminated
  • Locally Advanced HER2-positive Breast Cancer
  • Drug: Paclitaxel; trastuzumab; doxorrubicin; cyclophosphamide
  • Sao Paulo, Brazil
    Instituto do Cancer do Estado de Sao Paulo
May 20, 2014

Multiple Myeloma Trial in Brazil (Thalidomide plus dexamethasone, Dexamethasone)

Completed
  • Multiple Myeloma
  • Campinas, São Paulo, Brazil
  • +3 more
Feb 14, 2011